Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab.

Qureshi AI, Saad M, Zaidat OO, Suarez JI, Alexander MJ, Fareed M, Suri K, Ali Z, Hopkins LN.

Stroke. 2002 Jul;33(7):1916-9.

2.

Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement.

Arab D, Yahia AM, Qureshi AI.

Int J Cardiovasc Intervent. 2003;5(2):61-6. Review.

PMID:
12745860
3.

Systematic review of observational research studying the long-term use of antithrombotic medicines following intracerebral hemorrhage.

Flynn RW, MacDonald TM, Murray GD, Doney AS.

Cardiovasc Ther. 2010 Jun;28(3):177-84. doi: 10.1111/j.1755-5922.2009.00118.x. Epub 2010 Mar 7. Review.

PMID:
20337638
4.
5.

Fatal pulmonary haemorrhage with the combined use of abciximab and fibrinolytic agent.

Tan HC, Low A, Ng KS, Budiono B, Sutandar A, Chia BL, Lim YT.

Singapore Med J. 2002 Nov;43(11):587-9. Review.

PMID:
12680530
6.

Spotlight on abciximab in patients with ischemic heart disease undergoing percutaneous coronary revascularization.

Ibbotson T, McGavin JK, Goa KL.

Am J Cardiovasc Drugs. 2003;3(5):381-6. Review.

PMID:
14728074
8.

Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials.

De Luca G, Verdoia M, Suryapranata H.

Atherosclerosis. 2012 Jun;222(2):426-33. doi: 10.1016/j.atherosclerosis.2012.02.041. Epub 2012 Mar 7. Review.

PMID:
22483166

Supplemental Content

Support Center